Alpa Laboratories Limited (ALPA)
ISIN: INE385I01010 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
62.8
-0.3(-0.48%)

Alpa Laboratories Limited engages in manufacturing and selling pharmaceutical finished dosage forms in India. It offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human use. The company also provides boluses, injections, and intra-mammary infusions for veterinary use. In addition, the company provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. It sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to South and Central America, Africa, and Asia, and CIS countries. Alpa Laboratories Limited was founded in 1967 and is based in Indore, India.

Pricing Updates

TODAY'S HIGH

64.75

TODAY'S LOW

62.1

52 WEEK HIGH

108.8

52 WEEK LOW

47.35

Major Holders

% of Shares Held by
All Insider

57.29%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

132.55 Cr.

ETERPRISE VALUE

76.44 Cr.

NO. OF SHARES

2.10 Cr.

BOOK VALUE

54.06

DIV. YIELD

None%

DEBT

13.90 Cr.

GROSS PROFIT

46.93 Cr.

CASH

70.19 Cr.

REVENUE

101.23 Cr.

REVENUE/SHARE

48.103

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-14.92 Cr.7.90 Cr.-11.60 Cr.-11.87 Cr.
Change To Liabilities-92.19 Lakhs12.72 Cr.-1.19 Cr.1.89 Cr.
Total cashflows from Investing Activities-15.58 Cr.5.86 Cr.-11.16 Cr.-14.66 Cr.
Net Borrowings5.83 Cr.26.35 Lakhs-1.27 Cr.-4.32 Cr.
Total Cash from Financing Activities5.59 Cr.18.57 Lakhs-1.34 Cr.-4.77 Cr.
Other Liabilities4.06 Cr.-53.94 Lakhs8.54 Lakhs3.27 Cr.
Total Assets0000
Net Income14.09 Cr.7.24 Cr.1.85 Cr.1.01 Cr.
Change in Cash-8 Cr.4.35 Cr.5.27 Cr.-20.44 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities1.98 Cr.-1.69 Cr.17.78 Cr.-1 Cr.
Depreciation1.65 Cr.1.22 Cr.1.14 Cr.1.09 Cr.
Other Cashflows from Investing Activities1.52 Cr.79.35 Lakhs1.61 Cr.3.85 Cr.
Dividends Paid0000
Change to Inventory1.09 Cr.-4 Cr.1.48 Cr.-31.56 Lakhs
Change to Account Receivables-8.39 Cr.-18.50 Cr.9.77 Cr.-7.23 Cr.
Other Cashflows from Financing Activities-24.29 Lakhs-7.78 Lakhs-7.68 Lakhs-44.92 Lakhs
Change to Net Income-9.61 Cr.15.89 Lakhs4.63 Cr.-72.51 Lakhs
Capital Expenditures-2.19 Cr.-3.21 Cr.-2.54 Cr.-85.31 Lakhs

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax19.56 Cr.10.78 Cr.2.90 Cr.2.75 Cr.
Minority InterestNoneNoneNoneNone
Net Income9.02 Cr.7.40 Cr.4.71 Cr.24.01 Lakhs
Selling General Administrative11.93 Cr.12 Cr.12.16 Cr.12.58 Cr.
Gross Profit36.17 Cr.32.79 Cr.30.69 Cr.24.88 Cr.
Ebit9.02 Cr.7.40 Cr.4.71 Cr.24.01 Lakhs
Operating Income9.02 Cr.7.40 Cr.4.71 Cr.24.01 Lakhs
Other Operating Expenses13.56 Cr.12.16 Cr.12.67 Cr.10.96 Cr.
Interest Expense-24.29 Lakhs-2.61 Lakhs-9.51 Lakhs-47.68 Lakhs
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense5.47 Cr.3.53 Cr.1.05 Cr.1.74 Cr.
Total Revenue112.26 Cr.97.55 Cr.85.96 Cr.77.98 Cr.
Total Operating Expenses103.23 Cr.90.14 Cr.81.25 Cr.77.74 Cr.
Cost of Revenue76.08 Cr.64.75 Cr.55.27 Cr.53.09 Cr.
Total Other Income Expense Net10.53 Cr.3.38 Cr.-1.80 Cr.2.51 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.14.09 Cr.7.24 Cr.1.85 Cr.1.01 Cr.
Net Income Applicable to Common Shares14.09 Cr.7.24 Cr.1.85 Cr.1.01 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets10.43 Lakhs5.51 Lakhs00
Capital Surplus054.96 Cr.54.96 Cr.54.96 Cr.
Total Liabilities33.53 Cr.32.72 Cr.20.97 Cr.22.72 Cr.
Stock Holder Equity121.73 Cr.107.64 Cr.100.37 Cr.98.49 Cr.
Minority Interest0000
Other Liabilities12.78 Cr.6.21 Cr.5.66 Cr.6.25 Cr.
Total Assets155.26 Cr.140.36 Cr.121.35 Cr.121.21 Cr.
Common Stock21.04 Cr.21.04 Cr.21.04 Cr.21.04 Cr.
Retained Earnings031.64 Cr.24.37 Cr.22.49 Cr.
Other Liabilities-1 k21.60 Lakhs-1 k1 k
Good Will0002.02 Cr.
Treasury Stock100.69 Cr.000
Other Assets1.04 Cr.33.85 Lakhs1.37 Cr.60.13 Lakhs
Cash2.50 Cr.1.80 Cr.4.97 Cr.14.91 Lakhs
Current Liabilities31.40 Cr.32.50 Cr.20.78 Cr.22.31 Cr.
Long Term Asset Charges0092.58 Lakhs17.10 Lakhs
Short Long Term Debt3.72 Cr.18.29 Lakhs21.93 Lakhs20.24 Lakhs
Other Stockholder Equity100.69 Cr.000
Property Plant Equipment9.21 Cr.8.73 Cr.7.21 Cr.5.87 Cr.
Total Cur. Assets138.96 Cr.121.09 Cr.95.47 Cr.94.08 Cr.
Long Term Investments5.93 Cr.10.15 Cr.17.28 Cr.18.62 Cr.
Net Tangible Assets121.62 Cr.107.58 Cr.100.37 Cr.96.47 Cr.
Short Term Investments68.69 Cr.000
Net Receivables38.75 Cr.38.12 Cr.26.57 Cr.37.73 Cr.
Long Term Debt2.12 Cr.91 k19.20 Lakhs41.13 Lakhs
Inventory15.46 Cr.16.55 Cr.12.55 Cr.14.03 Cr.
Accounts Payable14.89 Cr.24.73 Cr.13.69 Cr.13.18 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account